{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:29Z","timestamp":1790259929019,"version":"4.1.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with chronic hepatitis B virus (HBV) infection are characterized by impaired immune response that fails to eliminate HBV. Immune checkpoint molecules (ICMs) control the amplitude of the activation and function of immune cells, which makes them the key regulators of immune response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a multiparametric flow cytometry analysis of ICMs and determined their expression on intrahepatic lymphocyte subsets in untreated and treated patients with HBV in comparison with non-pathological liver tissue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The liver of untreated HBV patients exhibited a high accumulation of PD-1<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells, while the frequencies of 4-1BB<jats:sup>+<\/jats:sup> T cells, 4-1BB<jats:sup>+<\/jats:sup> natural killer (NK) cells, and TIM-3<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells were the highest in the chronic hepatitis phase. Our findings showed that the HBeAg status is linked to a distinct immune phenotype of intrahepatic CD8<jats:sup>+<\/jats:sup> T cells and NK cells characterized by high expression of ICMs, particularly 4-1BB. Importantly, antiviral treatment partially restored the normal expression of ICMs. Finally, we described important differences in ICM expression between intrahepatic and circulating NK cells in HBV patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study shows clear differences in the intrahepatic expression of ICMs on NK cells and T cells in chronic HBV patients depending on their clinical stage.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1489770","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:11:12Z","timestamp":1736917872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients"],"prefix":"10.3389","volume":"15","author":[{"given":"Lucile","family":"Dumolard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Noelle","family":"Hilleret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Mercey-Ressejac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theophile","family":"Gerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Jouvin-Marche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice N.","family":"Marche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Macek Jilkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.061","article-title":"Insights from antiviral therapy into immune responses to hepatitis B and C virus infection","volume":"156","author":"Rehermann","year":"2019","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00724-5","article-title":"The scientific basis of combination therapy for chronic hepatitis B functional cure","volume":"20","author":"Lim","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-019-09989-6","article-title":"Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift","volume":"13","author":"Liaw","year":"2019","journal-title":"Hepatol Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03127","article-title":"Advances in targeting the innate and adaptive immune systems to cure chronic hepatitis B virus infection","volume":"10","author":"Meng","year":"2019","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection","volume":"5","author":"Schuch","year":"2014","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","author":"Tian","year":"2013","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148111","article-title":"Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation","volume":"14","author":"Dumolard","year":"2023","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2007.07.038","article-title":"PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients","volume":"45","author":"Peng","year":"2008","journal-title":"Mol Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1053\/j.gastro.2008.03.037","article-title":"Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B","volume":"134","author":"Zhang","year":"2008","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158903","article-title":"Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells","volume":"133","author":"Nkongolo","year":"2023","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325915","article-title":"Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients","volume":"72","author":"Zhang","year":"2023","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","article-title":"Therapeutic potential of co-signaling receptor modulation in hepatitis B","volume":"187","author":"Andreata","year":"2024","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu016","article-title":"Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels","volume":"209","author":"Jouvin-Marche","year":"2014","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3214917","DOI":"10.1155\/2017\/3214917","article-title":"Sex differences in spontaneous degranulation activity of intrahepatic natural killer cells during chronic hepatitis B: association with estradiol levels","volume":"2017","author":"Macek Jilkova","year":"2017","journal-title":"Mediators Inflammation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095614","article-title":"Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C","volume":"9","author":"Fugier","year":"2014","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/cells10102671","article-title":"Increased intrahepatic expression of immune checkpoint molecules in autoimmune liver disease","volume":"10","author":"Macek Jilkova","year":"2021","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.649311","article-title":"Insights into human intrahepatic NK cell function from single cell RNA sequencing datasets","volume":"12","author":"Jameson","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.12.005","article-title":"T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B","volume":"52","author":"Ju","year":"2010","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(13)60061-2","article-title":"Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B","volume":"12","author":"Zhang","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162115","article-title":"IL-2(high) tissue-resident T cells in the human liver: Sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.01.026","article-title":"TIM-3 as a marker of exhaustion in CD8+ T cells of active chronic hepatitis B patients","volume":"128","author":"Mohammadizad","year":"2019","journal-title":"Microbial Pathogenesis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.21037\/aob-20-38","article-title":"Tim-3 expression on t cells is correlated with liver inflammation, fibrosis and virological characteristics in treatment-na\u00efve chronic hepatitis B patients: a cross-sectional study","volume":"5","author":"Gu","year":"2020","journal-title":"Ann Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000733","article-title":"New emerging targets in cancer immunotherapy: CD137\/4-1BB costimulatory axis","volume":"4","author":"Etxeberria","year":"2020","journal-title":"ESMO Open"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301217","article-title":"Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization","volume":"193","author":"Willoughby","year":"2014","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s11658-020-00219-8","article-title":"Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response","volume":"25","author":"Bagheri","year":"2020","journal-title":"Cell Mol Biol Lett"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1053\/j.gastro.2012.08.041","article-title":"Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV","volume":"143","author":"Fisicaro","year":"2012","journal-title":"Gastroenterology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60095.sa2","article-title":"Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion","volume":"10","author":"Marotel","year":"2021","journal-title":"Elife"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317071","article-title":"Fine needle aspirates comprehensively sample intrahepatic immunity","volume":"68","author":"Gill","year":"2019","journal-title":"Gut"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22419","article-title":"Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion","volume":"48","author":"Evans","year":"2008","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9509-7","article-title":"Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate","volume":"31","author":"Trehanpati","year":"2011","journal-title":"J Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i28.9486","article-title":"Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B","volume":"20","author":"Li","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3892\/br.2014.217","article-title":"Expression levels of CD28, CTLA-4, PD-1 and Tim-3 as novel indicators of T-cell immune function in patients with chronic hepatitis B virus infection","volume":"2","author":"Wang","year":"2014","journal-title":"BioMed Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2019-0128","article-title":"FoxP3, PD-1 and CTLA-4 are decreased significantly after a tenofovir therapy in patients with chronic hepatitis B","volume":"15","author":"Cho","year":"2020","journal-title":"Future Virol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/cei.13486","article-title":"Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients","volume":"202","author":"Pang","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"100388","DOI":"10.1016\/j.jhepr.2021.100388","article-title":"Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection","volume":"4","author":"van Buuren","year":"2022","journal-title":"JHEP Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00441","article-title":"Age-dependent immune events during HBV infection from birth to adulthood: an alternative interpretation","volume":"5","author":"Bertoletti","year":"2014","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.2015.30.issue-8","article-title":"Gender disparity in chronic hepatitis B: Mechanisms of sex hormones","volume":"30","author":"Wang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.12688\/wellcomeopenres","article-title":"Sexual dimorphism in chronic hepatitis B virus (HBV) infection: evidence to inform elimination efforts","volume":"7","author":"Brown","year":"2022","journal-title":"Wellcome Open Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1489770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:11:18Z","timestamp":1736917878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1489770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2024.1489770"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1489770","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1489770"}}